KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Non Operating Investment Income: 2010-2012

Historic Non Operating Investment Income for Novavax (NVAX) over the last 1 years, with Dec 2012 value amounting to $502,000.

  • Novavax's Non Operating Investment Income was N/A to $502,000 in Q4 2012 from the same period last year, while for Dec 2012 it was $101,000, marking a year-over-year change of. This contributed to the annual value of $267,000 for FY2013, which is 164.36% up from last year.
  • Novavax's Non Operating Investment Income amounted to $502,000 in Q4 2012, which was up 225.19% from -$401,000 recorded in Q3 2012.
  • Over the past 5 years, Novavax's Non Operating Investment Income peaked at $1.3 million during Q2 2011, and registered a low of -$401,000 during Q3 2012.
  • Moreover, its 3-year median value for Non Operating Investment Income was $101,000 (2012), whereas its average is $343,857.
  • Within the past 5 years, the most significant YoY rise in Novavax's Non Operating Investment Income was 250.75% (2012), while the steepest drop was 107.75% (2012).
  • Novavax's Non Operating Investment Income (Quarterly) stood at $1.1 million in 2010, then tumbled by 106.27% to $1.3 million in 2011, then slumped by 107.75% to $502,000 in 2012.
  • Its last three reported values are $502,000 in Q4 2012, -$401,000 for Q3 2012, and -$101,000 during Q2 2012.